CTNNB1 and migraine disorder: Although it is suggested that valproate (VPA) can treat migraine by activating the wnt/beta-catenin pathway, which regulates cell regeneration and differentiation, especially glial cell differentiation and regeneration (Wang et al., 2010b; Moon et al., 2018), the specific regulation mechanism is not clear.